Shanghai Zj Bio-Tech's Ebola Test Kit Gains WHO Emergency Use Listing

Stock News
07/06

Shanghai Zj Bio-Tech Co.,Ltd. (ASX: 688317) has announced that its Ebola virus nucleic acid detection kit (using fluorescent PCR methodology) has been included in the World Health Organization's Emergency Use List (EUL).

The company received formal notification from the WHO, with the listing effective from July 2, 2026.

This specific product is designed to detect the Bundibugyo species of the Ebola virus.

Securing a place on the WHO EUL signifies the organization's validation and approval of the company's product.

This listing provides a procurement reference for WHO member states and other potential buyers, which is expected to facilitate the promotion and sales of the company's Ebola-related products in relevant overseas markets.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10